Therapeutic effects of nitric oxide-aspirin hybrid drugs - Test2 - elhamkhani - TriplyDB

Therapeutic effects of nitric oxide-aspirin hybrid drugs

Therapeutic effects of nitric oxide-aspirin hybrid drugs

http://www.wikidata.org/entity/Q28210282

about

Recent developments in nitric oxide donor drugs.Therapeutic potential of new hydrogen sulfide-releasing hybrids.A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.

P2860

Q36052815-7810EFE3-0B8D-4506-915E-1CE474B51A03 Q37960619-360FD269-5D96-4CC3-9AD2-E4096AFDB0E2 Q42417725-571DC4C7-1164-4D68-8DAD-49CEB72E9E40

P2860

Therapeutic effects of nitric oxide-aspirin hybrid drugs

http://www.wikidata.org/entity/Q28210282

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@ast

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@en

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@nl

type

label

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@ast

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@en

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@nl

prefLabel

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@ast

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@en

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@nl

P1433

Q28210282-55F1AB83-D217-4279-B16F-6353785E6EEC

P1476

Q28210282-D4670A15-CB07-436C-A3AB-F91E948D49C2

P2093

Q28210282-64C6A701-A42D-4EDF-8D5D-81CF6687B5CE

Q28210282-CBA62603-B430-4913-9900-D8DB7C3686E9

P2860

Q28210282-0210E1CD-7329-4F8D-B168-84C8A489D5B3

Q28210282-02FA3EEE-48FE-4A06-8D07-391082ADA9B5

Q28210282-03854E92-3F88-4740-8B98-D409ADBF4FFF

Q28210282-06BB02F9-B708-4B60-8E6A-D975FD3720B4

Q28210282-07AEB2D4-2FFB-41AE-95D0-420E1BF63C3F

Q28210282-0F6EA1B5-5040-48E6-A18D-38520762AE71

Q28210282-12D2ACDC-2473-43B1-95C8-5DE5D72656DA

Q28210282-16B9CA49-C408-41C7-ACAE-C380C01301C7

Q28210282-1E21D4C8-5AAA-4D76-A56D-A9B6BAE0ACEA

Q28210282-1F978275-C9B8-45DE-A60A-B03B8A7BB9E1

P304

Q28210282-66B11B3F-3400-4C98-B0B6-FFD3A229B62C

P31

Q28210282-C01FE2EC-BEA8-47A7-B224-AF3AF13B94F3

P356

Q28210282-0BA66E76-D530-4FF7-9033-C3380E606119

P407

Q28210282-485D4885-F3C9-45CE-AD4B-F4BAEABAE112

P433

Q28210282-B5307668-9FA1-4228-A49E-4A2B18ADD685

P478

Q28210282-7CBAE21B-6918-412E-B571-03555223979D

P50

Q28210282-448D85CF-F6F7-4935-BAF5-840FC98EF657

P577

Q28210282-64E2E9D3-F237-4ED5-BC53-4D3207C60728

P698

Q28210282-666F7C35-0B6C-4CE9-875D-BF697258167F

P921

Q28210282-0B8B413A-AC24-48D7-9C81-68B72A7366D0

P356

14728222.10.6.911

P1433

Expert Opinion on Therapeutic Targets

P1476

Therapeutic effects of nitric oxide-aspirin hybrid drugs

@en

P2093

Adriano G Rossi

http://www.w3.org/2001/XMLSchema#string

Catriona M Turnbull

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Atherosclerosis — An Inflammatory Disease

Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3

Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

The role of aspirin-triggered lipoxins in the mechanism of action of aspirin

Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins

P304

911-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.10.6.911

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17105376

http://www.w3.org/2001/XMLSchema#string

P921